EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 20-Oct-2026 16:16 ET (20-Oct-2026 20:16 GMT/UTC)

Getting paid to vape? Researchers say that’s a dangerous combination

Medical University of South Carolina
Peer-Reviewed Publication

The rise of “smart” vaping devices that combine nicotine or cannabis with cryptocurrency rewards, gamification and artificial intelligence is raising new public health concerns. In a New England Journal of Medicine perspective, MUSC Hollings Cancer Center researchers Amanda Palmer, Ph.D., Tracy Smith, Ph.D., and Benjamin Toll, Ph.D., warn that these products may reinforce addictive behaviors by rewarding users for vaping rather than quitting. The researchers are particularly concerned about their potential appeal to adolescents, young adults and people experiencing financial hardship, as well as regulatory gaps that have struggled to keep pace with rapidly evolving vaping technology. They are calling for greater scrutiny of these products before they become more widespread.

Journal: New England Journal of Medicine

ASTRO: Targeted radioactive therapy for prostate cancer, new SBRT approaches, personalized radiation and more

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share new research and clinical trial findings at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, including studies on new treatment approaches for prostate, bile duct and head and neck cancers, personalized radiation therapy based on genetic risk, and advances in targeted radiation and radioligand therapy designed to improve cancer control while limiting treatment side effects.

Meeting: American Society for Radiation Oncology Annual Meeting

ASTRO: UT MD Anderson highlights advances in radiation oncology

University of Texas M. D. Anderson Cancer Center
Reports and Proceedings

Experts from The University of Texas MD Anderson Cancer Center will present nearly 70 abstracts at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting. Along with UT MD Anderson’s top abstracts, selected oral presentations below highlight important findings to ensure radiation is accurately delivered and to validate a modern genomic test with a historical data set.

Meeting: American Society for Radiation Oncology Annual Meeting

Mayo Clinic experts present radiation oncology research at ASTRO 2026

Mayo Clinic
Reports and Proceedings

Mayo Clinic researchers will present findings on emerging technologies, precision treatments and new radiation therapy techniques at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting.

Meeting: American Society for Radiation Oncology Annual Meeting

Additional research highlights from the 2026 ASTRO Annual Meeting

American Society for Radiation Oncology
Reports and Proceedings

In addition to the nine studies that will be featured in news briefings at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, the following studies on advances in radiation medicine and cancer care were recommended by ASTRO experts as highlights for news professionals.

Treating a deadly brain tumor before it recurs? AI tool may help

University of California - San Francisco
Peer-Reviewed Publication

A new AI-based model can predict where glioblastoma is most likely to return after initial surgery, potentially giving doctors a chance to treat it before it becomes visible on MRI.

Journal: Science Advances

UT MD Anderson shares latest research breakthroughs

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

Phase 3 results show promise for new immunotherapy advanced lung cancer

Researchers find new role for B7-H3 in cancer immunity and a combination approach that improved outcomes in preclinical models of prostate cancer

Insights suggest which patients are most likely to benefit from CAR T cell therapy and that many patients with appendix cancer could avoid chemotherapy

Blood tests could monitor bone metastases in patients with medullary thyroid cancer

Scientists make advances in detecting risk of and treatment for immunotherapy-related colitis and treatment-induced lung inflammation

Metastatic colorectal cancer is more advanced in younger patients than older ones, but they survive longer with the disease, study finds

American College of Surgeons
Reports and Proceedings

Metastatic colorectal cancer (mCRC) continues to increase in patients aged 45 years or younger, and their longer survival and different disease patterns compared with older patients may warrant more aggressive scrutiny of gastrointestinal symptoms, according to new study findings.

Meeting: American College of Surgeons Clinical Congress 2026

Artificial intelligence model predicts pancreatic cancer risk 3 years before diagnosis

American College of Surgeons
Reports and Proceedings

Researchers at Mayo Clinic have designed an artificial intelligence model that can potentially predict an individual’s risk of developing pancreatic cancer years before diagnosis.

Meeting: American College of Surgeons Clinical Congress 2026

Appendectomy for appendicitis associated with 58% lower colorectal cancer risk than antibiotics alone

American College of Surgeons
Reports and Proceedings

Patients who underwent an appendectomy for acute appendicitis had a significantly lower subsequent risk of colorectal cancer than similar patients treated with antibiotics alone, according to new research.

Meeting: American College of Surgeons Clinical Congress 2026

26
27
28
29
30